|
2024
|
Invention
|
Farnesoid x receptor modulators.
The present invention provides a compound of formula (I): or a ... |
|
|
Invention
|
Preparation and uses of obeticholic acid.
The present invention relates to obeticholic acid:
T... |
|
|
Invention
|
Methods and intermediates for the preparation of bile acid derivatives. The present disclosure re... |
|
2023
|
Invention
|
Crystalline forms of a farnesoid x receptor agonist. Provided are crystalline forms of a farnesoi... |
|
|
Invention
|
Uses of farnesoid x receptor agonists. The present invention relates to FXR agonist compounds and... |
|
|
Invention
|
Methods for ameliorating cognitive impairment using bile acid derivatives. The disclosure relates... |
|
|
Invention
|
Farnesoid x receptor modulators.
The present invention provides a compound of formula (I):
The... |
|
|
Invention
|
Combination therapy.
The present disclosure relates to a combination of an FXR agonist and a fib... |
|
|
Invention
|
Combination therapy. The present disclosure relates to a combination of an FXR agonist and a fibr... |
|
2022
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases, disorders and conditions |
|
|
Invention
|
Isotopically labeled bile acid derivatives.
The present application relates to isotopically labe... |
|
|
Invention
|
Tgr5 modulators and methods of use thereof. The application relates to compounds of formula A:
... |
|
|
Invention
|
Pharmaceutical compositions for combination therapy.
The present invention relates to a pharmace... |
|
2021
|
Invention
|
Compositions of obeticholic acid and methods of use.
The disclosure relates to obeticholic acid ... |
|
|
Invention
|
Methods of treating coronaviral infection with obeticholic acid. This present application provide... |
|
|
Invention
|
Methods of using obeticholic acid.
The disclosure relates to methods of using obeticholic acid o... |
|
|
Invention
|
Methods and intermediates for the preparation of bile acid derivatives.
The present disclosure r... |
|
|
Invention
|
Farnesoid x receptor modulators. The present application provides a compound of formula I:
are ... |
|
|
Invention
|
Treatment of fibrosis using fxr ligands.
The present invention relates to a method for inhibitin... |
|
2020
|
P/S
|
Providing a website featuring information about health and wellness, namely, information in the f... |
|
|
Invention
|
Tgr5 modulators and methods of use thereof.
The invention relates to compounds of Formula A:
T... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of liver diseases, dis... |
|
|
Invention
|
3-desoxy derivative and pharmaceutical compositions thereof. The present application provides Com... |
|
|
Invention
|
Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of ch... |
|
|
Invention
|
Methods of diagnosis and treatment of liver diseases using obeticholic acid.
The disclosure rela... |
|
|
Invention
|
Methods of diagnosis and treatment of liver diseases using obeticholic acid. The disclosure relat... |
|
|
Invention
|
Compositions of obeticholic acid and methods of use. The disclosure relates to obeticholic acid f... |
|
|
Invention
|
Treatment and prevention of intestinal inflammatory diseases with a bile acid derivative.
The pr... |
|
|
Invention
|
Treatment and prevention of intestinal inflammatory diseases with a bile acid derivative. e.g.e.g... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharma... |
|
2019
|
Invention
|
Farnesoid x receptor modulators. The present invention provides a compound of formula (I):
6 are... |
|
|
Invention
|
Methods of using obeticholic acid. The disclosure relates to methods of using obeticholic acid or... |
|
|
P/S
|
Pharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations... |
|
|
P/S
|
Downloadable information, slide decks, video content, brochures, publications in the field of liv... |
|
|
P/S
|
Downloadable information, namely, slide decks, consisting of text, images, photographs, tables, g... |
|
|
P/S
|
Providing a website featuring information in the field of liver diseases and treatments |
|
2018
|
Invention
|
Treatment of fibrosis using fxr ligands. The present invention relates to a method for inhibiting... |
|
|
Invention
|
Isotopically labeled bile acid derivatives. The present application relates to isotopically label... |
|
|
Invention
|
Crystalline forms of obeticholic acid.
The crystalline forms of obeticholic acid and methods of ... |
|
|
Invention
|
Pharmaceutical compositions of a bile acid derivative and microbiome and uses thereof.
The appli... |
|
2017
|
P/S
|
Pharmaceutical preparations for human use for the treatment of liver diseases |
|
|
P/S
|
Medical and scientific research, including conducting clinical trials and studies for pharmaceuti... |
|
|
P/S
|
Software application tool for use in the field of liver and intestinal diseases for sending, view... |
|
|
P/S
|
Software application tool for use in the field of liver and intestinal diseases. |
|
|
P/S
|
Providing a website featuring an online, non-downloadable software application tool for use in th... |
|
|
Invention
|
Film-coated tablet having high chemical stability of active ingredient. The present invention rel... |
|
2016
|
P/S
|
Providing funding and financial assistance for research, studies and programs related to disease ... |
|
|
Invention
|
Methods and intermediates for the preparation bile acid derivatives. The present invention relate... |
|
|
P/S
|
Providing information, news and commentary in the field of chronic liver diseases or gastrointest... |
|
|
P/S
|
Computer application software for mobile phones, portable media players, handheld computers, tabl... |
|
|
P/S
|
computer application software for mobile phones, portable media players, handheld computers, tabl... |
|
|
P/S
|
Computer application software for mobile phones, portable
media players, handheld computers, tab... |
|
2003
|
Invention
|
Steroids as agonists for fxr. The invention relates to compounds of formula (I):
wherein R is e... |
